Soufflé Therapeutics
PrivateLast Round
Series A
Oct 7, 2025
Total Funding Raised
$200M
Momentum Score
50 /100
Company Overview
Soufflé Therapeutics is a biotechnology company developing cell-specific small interfering RNA (siRNA) medicines for a range of diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Soufflé Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Soufflé Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 7, 2025 |
Key People
Founding team and executive leadership
Soufflé Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Breyer Capital | Series A |
| Janus Henderson Group | Series A |
| Temasek | Series A |
| Leaps by Bayer | Series A |
| Vida Ventures | Series A |
| Invus Opportunities | Series A |
| ARCH Venture Partners | Series A |
Soufflé Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Soufflé Therapeutics's valuation, stock price, and market status.
